Glaxo news from FierceHealthcare
NewsConflict of interest: FDA panelist voted against drug, had ties to competitor
Is the Food and Drug Administration (FDA) doing enough to keep its advisory panels clear of conflicts of interest? Recent disclosures suggest it isn't. An FDA advisory panel member who voted against Read more...
Cephalon settlement requires physician payments to be disclosed
Drugmaker Cephalon has agreed to pay $444 million to bring state and federal investigations of its sales and marketing practices to a close. As part of its settlement, Cephalon has agreed to plead Read more...
|
